TWiV 986: Clinical update with Dr. Daniel Griffin episode artwork

EPISODE · Feb 25, 2023 · 42 MIN

TWiV 986: Clinical update with Dr. Daniel Griffin

from This Week in Virology · host Vincent Racaniello

In his weekly clinical update Dr. Griffin discusses the efficacy and safety of two RSV vaccines in older adults, health care vaccine mandate remains as some push for an end, past SARS-CoV-2 infection protection against re-infection, a third vaccine dose equalizes the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens, Sotrovimab retains activity against SARS-CoV-2 Omicron variant BQ.1.1 in a non-human primate model, effect of higher-dose Ivermectin for 6 Days vs placebo on time to sustained recovery in outpatients with COVID-19, viral burden rebound in hospitalized patients with COVID-19 receiving oral antivirals in Hong Kong, serological response to vaccination in post-acute sequelae of COVID, sex differences in cardiovascular complications and mortality in hospital patients with COVID-19, association of COVID-19 vaccination with risk for incident diabetes after COVID-19, postacute sequelae of SARS-CoV-2 in university setting, the CDC's long-Covid deception, and podcast companies, once walking on air, feel the strain of gravity. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode RSV prefusion F protein vaccine in older adults (NEJM) Efficacy and safety of an Ad26.RSV.preF–RSV preF protein vaccine (NEJM) Health care vaccine mandate remains as some push for an end (AP) Past SARS-CoV-2 infection protection against re-infection (The Lancet) A third vaccine dose equalizes the levels of effectiveness and immunogenicity of COVID-19 vaccine regimens (medRxiv) Sotrovimab retains activity against SARS-CoV-2 Omicron variant in primate model (bioRxiv) Effect of higher-dose Ivermectin for 6 days vs placebo in patients with COVID-19 (JAMA) Viral burden rebound in patients with COVID-19 receiving oral antivirals (The Lancet) Serological response to vaccination in post-acute sequelae of COVID (BMC) Sex differences in cardiovascular complications and mortality in patients with COVID-19 (BMI) Association of COVID-19 vaccination with risk for incident diabetes after COVID-19 (JAMA) Postacute sequelae of SARS-CoV-2 in university setting (CDC) The CDC's Long-Covid deception (WSJ) Podcast companies, once walking on air, feel the strain of gravity (NYT) Contribute to our ASTMH fundraiser at PWB Dr. Griffin's treatment guide (pdf) Letters read on TWiV 986 Don't crush Paxlovid (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]

Episode metadata supplied by the publisher feed · Published Feb 25, 2023

Embed this episode

NOW PLAYING

TWiV 986: Clinical update with Dr. Daniel Griffin

0:00 42:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of This Week in Virology?

This episode is 42 minutes long.

When was this This Week in Virology episode published?

This episode was published on February 25, 2023.

Can I download this This Week in Virology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!